Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6SYI

C-TERMINAL DOMAIN OF INFLUENZA POLYMERASE PA SUBUNIT AND OPTIMIZED SMALL PEPTIDE INHIBITOR

Summary for 6SYI
Entry DOI10.2210/pdb6syi/pdb
DescriptorPolymerase acidic protein, PB1-11, TRIETHYLENE GLYCOL, ... (5 entities in total)
Functional Keywordsneuraminidase, influenza, complex, viral protein
Biological sourceInfluenza A virus (A/Wisconsin/629-D00036/2009(H1N1))
More
Total number of polymer chains2
Total formula weight54624.58
Authors
Hejdanek, J.,Pachl, P. (deposition date: 2019-09-30, release date: 2020-11-25, Last modification date: 2024-01-24)
Primary citationHejdanek, J.,Radilova, K.,Pachl, P.,Hodek, J.,Machara, A.,Weber, J.,Rezacova, P.,Konvalinka, J.,Kozisek, M.
structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor.
Antiviral Res., 185:104971-104971, 2020
Cited by
PubMed Abstract: Influenza viruses can cause severe respiratory infections in humans, leading to nearly half a million deaths worldwide each year. Improved antiviral drugs are needed to address the threat of development of novel pandemic strains. Current therapeutic interventions target three key proteins in the viral life cycle: neuraminidase, the M2 channel and RNA-dependent-RNA polymerase. Protein-protein interactions between influenza polymerase subunits are potential new targets for drug development. Using a newly developed assay based on AlphaScreen technology, we screened a peptide panel for protein-protein interaction inhibitors to identify a minimal PB1 subunit-derived peptide that retains high inhibition potential and can be further modified. Here, we present an X-ray structure of the resulting decapeptide bound to the C-terminal domain of PA polymerase subunit from pandemic isolate A/California/07/2009 H1N1 at 1.6 Å resolution and discuss its implications for the design of specific, potent influenza polymerase inhibitors.
PubMed: 33166574
DOI: 10.1016/j.antiviral.2020.104971
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon